GigaDevice has announced the official launch of the Digital Power Joint Lab in collaboration with Navitas Semiconductor.
The U.S. Food and Drug Administration (FDA) is reviewing Corcept’s application to market relacorilant in the United States to treat patients with platinum-resistant ovarian cancer. The FDA’s ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果